Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2004 4
2005 2
2006 3
2007 1
2008 2
2009 3
2010 6
2011 8
2012 9
2013 7
2014 6
2015 9
2016 11
2017 13
2018 11
2019 15
2020 21
2021 18
2022 11
2023 14
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

160 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial.
Vilgrain V, Pereira H, Assenat E, Guiu B, Ilonca AD, Pageaux GP, Sibert A, Bouattour M, Lebtahi R, Allaham W, Barraud H, Laurent V, Mathias E, Bronowicki JP, Tasu JP, Perdrisot R, Silvain C, Gerolami R, Mundler O, Seitz JF, Vidal V, Aubé C, Oberti F, Couturier O, Brenot-Rossi I, Raoul JL, Sarran A, Costentin C, Itti E, Luciani A, Adam R, Lewin M, Samuel D, Ronot M, Dinut A, Castera L, Chatellier G; SARAH Trial Group. Vilgrain V, et al. Among authors: pereira h. Lancet Oncol. 2017 Dec;18(12):1624-1636. doi: 10.1016/S1470-2045(17)30683-6. Epub 2017 Oct 26. Lancet Oncol. 2017. PMID: 29107679 Clinical Trial.
Scaffolds and coatings for bone regeneration.
Pereira HF, Cengiz IF, Silva FS, Reis RL, Oliveira JM. Pereira HF, et al. J Mater Sci Mater Med. 2020 Mar 2;31(3):27. doi: 10.1007/s10856-020-06364-y. J Mater Sci Mater Med. 2020. PMID: 32124052 Review.
Factors impacting survival after transarterial radioembolization in patients with hepatocellular carcinoma: Results from the prospective CIRT study.
Kolligs F, Arnold D, Golfieri R, Pech M, Peynircioglu B, Pfammatter T, Ronot M, Sangro B, Schaefer N, Maleux G, Munneke G, Pereira H, Zeka B, de Jong N, Helmberger T; CIRT Principal Investigators. Kolligs F, et al. Among authors: pereira h. JHEP Rep. 2022 Nov 25;5(2):100633. doi: 10.1016/j.jhepr.2022.100633. eCollection 2023 Feb. JHEP Rep. 2022. PMID: 36593888 Free PMC article.
3D surgical planning of pediatric tumors: a review.
Pereira HR, Barzegar M, Hamadelseed O, Esteve AV, Munuera J. Pereira HR, et al. Int J Comput Assist Radiol Surg. 2022 Apr;17(4):805-816. doi: 10.1007/s11548-022-02557-8. Epub 2022 Jan 18. Int J Comput Assist Radiol Surg. 2022. PMID: 35043366 Review.
Prostatic artery embolisation versus medical treatment in patients with benign prostatic hyperplasia (PARTEM): a randomised, multicentre, open-label, phase 3, superiority trial.
Sapoval M, Thiounn N, Descazeaud A, Déan C, Ruffion A, Pagnoux G, Duarte RC, Robert G, Petitpierre F, Karsenty G, Vidal V, Murez T, Vernhet-Kovacsik H, de la Taille A, Kobeiter H, Mathieu R, Heautot JF, Droupy S, Frandon J, Barry Delongchamps N, Korb-Savoldelli V, Durand-Zaleski I, Pereira H, Chatellier G; PARTEM study group. Sapoval M, et al. Among authors: pereira h. Lancet Reg Health Eur. 2023 Jun 26;31:100672. doi: 10.1016/j.lanepe.2023.100672. eCollection 2023 Aug. Lancet Reg Health Eur. 2023. PMID: 37415648 Free PMC article.
Trends in trust of professional groups in Portugal during COVID-19.
Marina S, Pereira T, Pereira HP, Picoli R, Rodrigues-Fernandes H, Ricou M. Marina S, et al. Among authors: pereira hp. J Public Health Policy. 2023 Sep;44(3):489-498. doi: 10.1057/s41271-023-00430-9. Epub 2023 Aug 2. J Public Health Policy. 2023. PMID: 37532896 Review.
160 results